Buyout firm GTCR is in advanced talks on a potential acquisition of German generic drugmaker Stada Arzneimittel AG, people with knowledge of the matter said. GTCR is seeking to hammer out terms of a deal after rival bidder Clayton Dubilier & Rice dropped out of the race, the people said, asking not to be identified because the information is private. It has been discussing a valuation of roughly €10 billion ($11 billion) for Stada, the people said. Stada’s private equity owners Bain Capital and Cinven could reach a final agreement as soon as this month, the people said.
Read the full article: GTCR Is Said in Advanced Talks to Buy German Drugmaker Stada //
Source: https://news.bloomberglaw.com/private-equity/gtcr-is-said-in-advanced-talks-to-buy-german-drugmaker-stada